Ticker
DERMCompany Name
JOURNEY MEDICAL CORPSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 81.16M | $ 39.15M | 48.23% |
3/31/2025 | $ 84.96M | $ 37.39M | 44.01% |
12/31/2024 | $ 80.24M | $ 35.26M | 43.94% |
9/30/2024 | $ 64.04M | $ 33.11M | 51.71% |
6/30/2024 | $ 65.19M | $ 51.88M | 79.58% |
3/31/2024 | $ 66.57M | $ 52.97M | 79.57% |
12/31/2023 | $ 76.85M | $ 52.52M | 68.34% |
9/30/2023 | $ 65.92M | $ 51.53M | 78.17% |
6/30/2023 | $ 69.75M | $ 32.31M | 46.33% |
3/31/2023 | $ 95.85M | $ 33.56M | 35.02% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for JOURNEY MEDICAL CORP is calculated as follows: GP [ $ 29.94M ] / Assets [ $ 51.91M ]
(=) GPA [ 57.68% ]
Minimum
Dec 31, 2021
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 4.14K |
---|---|
min | -50.32% |
max | 83.98% |
average | 20.15% |
median | 15.34% |
std | 19.95% |